De Novo Seq

De novo sequencing is a technique that directly sequences unknown proteins or peptides without the need for reference sequences. This technology is crucial in proteomics research, particularly for new protein discovery, antibody epitope mapping, protein post-translational modification analysis, and biopharmaceuticals. De novo sequencing provides high-resolution sequence information, revealing the primary structure of proteins and supporting scientific research and applications.

 

MtoZ Biolabs offers professional de novo sequencing services using advanced mass spectrometry technology and bioinformatics tools to deliver accurate and comprehensive protein sequence information.

 

Analysis Workflow

 



 

Services at MtoZ Biolabs

Protein De Novo Sequencing

Peptide De Novo Sequencing

Monoclonal Antibody De Novo Sequencing

Protein De Novo Sequencing and Mutation Analysis

 

Service Advantages

 



 

Sample Submission Requirements

 



For detailed sample submission instructions, please consult our technical team.

 

Applications

New Protein Discovery: Identify unknown or newly discovered proteins through de novo sequencing, expanding the scope of proteomics research.

 

Antibody Epitope Mapping: Precisely determine antibody-binding epitope sequences, providing critical data for antibody drug development.

 

Post-Translational Modification Analysis: Reveal protein post-translational modifications and understand their roles in functional regulation.

 

Biopharmaceuticals: Provide accurate sequence information for protein drugs in biopharmaceuticals, supporting drug development and quality control.

 

Deliverables

1. Experimental Procedures

2. Relevant Mass Spectrometry Parameters

3. Detailed Information on Protein Sequences

4. Mass Spectrometry Images

5. Raw Data